Key Business and Financial Highlights22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across...
Reports positive Phase 1 study results for Voriconazole Inhalation Powder and Tacrolimus Inhalation PowderAwarded subcontract license by U.S. government agency...
Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second quarter 2021Epinephrine program and development strategy to...
IRVINE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused...
CHICAGO--(BUSINESS WIRE)--Mar 9, 2021--Oak Street Health, Inc. (NYSE: OSH) (the “Company”), a network of value-based, primary care centers for adults...
PCDH19 related epilepsy (PCDH19-RE) Phase 2 Violet Study Proof-of-Concept Trial (n=21) shows a median 61.5% reduction in seizure frequency for...
Highlights include continued progress with phase IIb psilocybin therapy clinical trial, launch of first Centre of Excellence, and expansion of...
TipRanksAI Is Right here 3 ‘Strong Buy’ Stocks That Stand to ProfitHello tech is the awesome kid of expense sectors,...
BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Sale of Manufacturing Operations to Catalent with net proceeds of ~$74 millionAnnual operating expenses cut by ~$40 million via sale,...
BOSTON--(Organization WIRE)--Mar 5, 2021--Tri-Continental Company (the “Corporation”) (NYSE: TY ) currently declared a to start with quarter ordinary cash flow...
Organization administration to host a webcast and conference phone to present a small business update and overview financial success at...
Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and...
NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today provided a business update and...
SAN DIEGO, March 04, 2021 (Globe NEWSWIRE) -- Retail Prospect Investments Corp. (NASDAQ: ROIC) will situation economic and operational results...
- Biologics License Application (BLA) for IV efgartigimod accepted for review by U.S. Food and Drug Administration (FDA) for generalized...
– Company on track to present data from Phase 2b ReDUX4 trial with losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in...
HANOVER, Md.--(BUSINESS WIRE)--Mar 4, 2021--Ciena® Corporation (NYSE: CIEN), a networking systems, services and software company, today announced unaudited financial results...
